Weekly 70 mg/m2 Carfilzomib for Multiple Myeloma Patients Refractory to 27 mg/m2 Carfilzomib
Oncotherapeutics
Oncotherapeutics
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute